JPS63294852A - Cholangiocarcinoma treatment apparatus - Google Patents

Cholangiocarcinoma treatment apparatus

Info

Publication number
JPS63294852A
JPS63294852A JP62134355A JP13435587A JPS63294852A JP S63294852 A JPS63294852 A JP S63294852A JP 62134355 A JP62134355 A JP 62134355A JP 13435587 A JP13435587 A JP 13435587A JP S63294852 A JPS63294852 A JP S63294852A
Authority
JP
Japan
Prior art keywords
temperature
drainage tube
temp
heating
heating part
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP62134355A
Other languages
Japanese (ja)
Other versions
JPH0247219B2 (en
Inventor
Koji Yoshida
吉田 晃治
Hideki Saitsu
才津 秀樹
Hisashi Kumai
熊井 久之
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP62134355A priority Critical patent/JPS63294852A/en
Publication of JPS63294852A publication Critical patent/JPS63294852A/en
Publication of JPH0247219B2 publication Critical patent/JPH0247219B2/ja
Granted legal-status Critical Current

Links

Abstract

PURPOSE:To bring a cancerous cell to deformation necrosis, by providing a heating part by an electric heater and a thermometric body measuring the temp. of the heating part in the vicinity of the leading end part of a drainage tube in the treatment of cholangiocarcinoma and heating the heating part inserted in a cancerous part to specific temp. CONSTITUTION:After percutaneous bile duct drainage through the liver is performed for about one week to reduce jaundice, a drainage tube 1 is further pushed in toward the duodenum D to be allowed to pierce a cancerous part (k) and the position of a heating part 2 is allowed to coincide with the cancerous part (k). Next, the temp. setting of a temp. control means 4 is performed so as to hold the temp. of the heating part 2 to about 41 deg.C and a heating time is set to about 30min-1hr to perform the hyperthermia of the cancerous part (k). About 41 deg.C being the set temp. of the heating part 2 is the temp. bringing an cancerous cell to deformation necrosis and the temp. bringing a normal tissue cell to deformation necrosis is about 43 deg.C higher by 2 deg.C than said temp. and, therefore, by controlling the heating part 2 so as to enter a range of 41-43 deg.C, only the cancerous cell can be directly and effectively subjected to hyperthermia.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は、経皮経肝的胆道ドレナージを応用して胆管癌
を直接的に治療するための胆管癌治療装置に関する。
DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a cholangiocarcinoma treatment device for directly treating cholangiocarcinoma by applying percutaneous transhepatic biliary drainage.

(従来の技術と問題点) nu管癌はその解剖学的特殊性と診断が現在の医療レベ
ルから考えて非常に困難であるため、切除不能な例が多
い、幸い手術的に切除可能で十分根治的に切除し得−だ
と考えられた症例でも、5年生存率は20〜30%前後
であり、消化器癌の中では比較的予後不良の疾患である
(Conventional techniques and problems) Due to its anatomical peculiarities and the diagnosis of nu duct cancer, which is extremely difficult given the current medical level, many cases are unresectable. Fortunately, it is possible to remove the cancer surgically. Even in cases where it is thought that it can be completely resected, the 5-year survival rate is around 20-30%, making it a disease with a relatively poor prognosis among gastrointestinal cancers.

一般に胆管癌は黄痕を伴っているが、この黄痕が手術の
危険性を増大させることから(血清総ビリルビ、/1.
5”/a+以下3.9!、5−’八を以下9.2$、5
.1″″1″1八宜0$の手術死亡がある)0本邦では
まず経皮経肝的胆道ドレナージ(Pcrcutaneo
us Lranshepatic biliary d
lrainage、P T B D )を行なって、上
方に黄麻を軽減した後に根治術を行なっている。しかし
、黄痕を軽減するまでにはモ均1ケ月を要し、この間に
も癌は増大進展することから、最近、欧米では減資せず
に一期的に切除した方が良いとの意見が多くなっている
Generally, cholangiocarcinoma is accompanied by yellow scars, which increases the risk of surgery (serum total bilirubin, /1.
5"/a+ or less 3.9!, 5-'8 or less 9.2$, 5
.. In Japan, percutaneous transhepatic biliary drainage (Pcrcutaneo) is performed first.
US Lranshepatic biliary d
lrainage, PTBD) was performed to reduce the jutea upwardly, and then radical surgery was performed. However, it takes about a month for the yellow scar to be reduced, and the cancer continues to grow and progress during this time, so there has recently been an opinion in Europe and the United States that it is better to have it removed in one stage rather than reducing the cost. The number is increasing.

このように、胆管癌は黄庭を軽減して手術死亡を少なく
するか、手術の危険性は高くはなるが根治性を向トさせ
るために、敢てMU下に手術を行なうかの選択かむずか
しいとされている。
In this way, for cholangiocarcinoma, there is a choice between reducing the yellowing and reducing surgical mortality, or daringly performing surgery under MU in order to improve the curability, although the risk of surgery is high. It is considered difficult.

尚、切除不能胆管癌に対する治療方法としては、現在、
抗癌剤による療法、免疫療法、放射線療法等が行なわれ
ているか、いずれも間接的な療法てあって十分な効果を
あげ得るものではない。
Currently, the treatment methods for unresectable cholangiocarcinoma are:
Treatments with anticancer drugs, immunotherapy, radiotherapy, etc. are all indirect treatments and are not sufficiently effective.

(問題点を解決するための手段) 本発明は、上述のような問題点を解決するためになされ
たもので、その目的とするところは、経皮経肝的胆道ド
レナージを行ないながら胆管癌を直接的かつ局部的に温
熱治療することができる胆管癌治療装置の提供にあり、
この目的達成のために本発明では、体外から胆管内に至
るまでの間に挿入可能なサイズと可撓性とを備え、かつ
、胆管内に溜った胆汁を体外へ誘導するための中空部を
備えた中空パイプ状のドレナージ−チューブであって、 前記ドレナージ・チューブの先端部近くには電熱ヒータ
を熱源とする加温部と、該加温部の温度を測定する測温
体と?備え、かつ、ドレナージ・チューブの基端部側に
は測温体による検知温度に基づい゛C加温部の温度21
!J節か可ず先な温度調節り段を備えると共に、ドレナ
ージ・チューブの先端部で少なくとも加温部よりは基端
側の側壁には中空部内と外部との間を連通する流通穴を
備えた構成とした。
(Means for Solving the Problems) The present invention has been made to solve the above-mentioned problems, and its purpose is to treat bile duct cancer while performing percutaneous transhepatic biliary drainage. The purpose of the present invention is to provide a cholangiocarcinoma treatment device that can directly and locally perform thermal treatment.
In order to achieve this objective, the present invention has a hollow part that has a size and flexibility that can be inserted from outside the body to the inside of the bile duct, and that guides bile accumulated in the bile duct to the outside of the body. A hollow pipe-shaped drainage tube comprising: a heating section using an electric heater as a heat source near the distal end of the drainage tube; and a temperature measuring element for measuring the temperature of the heating section. In addition, on the proximal end side of the drainage tube, the temperature of the heating section 21 is measured based on the temperature detected by the thermometer.
! It is equipped with a temperature control stage as close as possible to the J section, and a communication hole is provided in the side wall of the distal end of the drainage tube, at least on the proximal side of the heating part, for communicating between the inside of the hollow part and the outside. The structure is as follows.

(作用) 本発明の胆管癌治療装置では、上述のように。(effect) In the cholangiocarcinoma treatment device of the present invention, as described above.

ドレナージ・チューブの先端部近くには電熱ヒータによ
る加温部と、該加温部の温度を測定する測温体とを備え
、かつ、ドレナージ・チューブの基端部側には測温体に
よる検知温度に基づいて加温部の温度調節が可能な温度
調節手段を備えたことて、隔部に挿通させた加温部を4
1”CjWj後に加温させることによって、癌細胞を変
性壊死に陥らせることができ、 また、加温部がドレナージ・チューブに備えられ、かつ
、該ドレナージ・チューブの先端部で少なくとも加温部
よりは基端側の側壁には中空部内と外部との間を挿通す
る流通穴を備えたことて、肝臓から放出された胆汁をド
レナージ・チューブの連通穴から中空部を経由して十二
指腸側へ誘導することができ。
Near the distal end of the drainage tube, there is a heating section using an electric heater and a temperature sensing element that measures the temperature of the heating section, and a temperature sensing element is installed near the proximal end of the drainage tube. Equipped with a temperature adjustment means capable of adjusting the temperature of the heating section based on the temperature, the heating section inserted through the septum is
By heating after 1"CjWj, cancer cells can be caused to undergo degenerative necrosis, and a heating section is provided in the drainage tube, and at least the heating section is heated at the distal end of the drainage tube. The proximal side wall is equipped with a circulation hole that passes between the inside of the hollow part and the outside, and bile released from the liver is guided from the communication hole of the drainage tube to the duodenum via the hollow part. can.

従って、経皮経肝的胆道ドレナージを行ないながら胆管
癌を直接的かつ局部的に加熱治療することができるよう
になる。
Therefore, it becomes possible to directly and locally heat treat cholangiocarcinoma while performing percutaneous transhepatic biliary drainage.

(実施例) 以ド、本発明の実施例を図面に基づいて詳述する。(Example) Hereinafter, embodiments of the present invention will be described in detail based on the drawings.

まず、実施例の構成を説明する。First, the configuration of the embodiment will be explained.

この実施例の胆管癌治療装RAは、第1図及び第2図に
示すように、ドレナージ・チューブlと、加温部2と、
測温体3と、温度調節手段4と、を主な構成として備え
ている。
As shown in FIGS. 1 and 2, the cholangiocarcinoma treatment device RA of this embodiment includes a drainage tube 1, a heating section 2,
The main components include a temperature measuring body 3 and a temperature adjusting means 4.

前記ドレナージ・チューブlは、一般的には経皮経肝的
111j道ドレナージを行なう際に用いられるものであ
って、体外から胆管B内に至るまでの間に挿入り能なサ
イズ(長さと直径)とn■撓性とを備え、かつ胆管B内
に溜った胆汁を体外へ誘導するための中空部lOを備え
た中空パイプ状に形成されている。
The drainage tube I is generally used when performing percutaneous transhepatic drainage, and has a size (length and diameter) that allows it to be inserted from outside the body to the inside of the bile duct B. ) and flexibility, and is formed in the shape of a hollow pipe with a hollow portion IO for guiding bile accumulated in the bile duct B to the outside of the body.

そして、この実施例ではドレナージ・チューブlの素材
として、耐熱性、耐酸性、耐アルカリ性に優れたフッ素
樹脂か用いられ、外W 5 mm、中空部10の内径2
嘗會、長さ5001−の中空パイプ状に形成されると共
に、該ドレナージ・チューブ1の先端部分を先細り状に
形成させCいる。
In this embodiment, a fluororesin having excellent heat resistance, acid resistance, and alkali resistance is used as the material for the drainage tube l, and the outer width is 5 mm and the inner diameter of the hollow part 10 is 2.
The drainage tube 1 is formed into a hollow pipe shape with a length of 5,000 mm, and the distal end portion of the drainage tube 1 is formed into a tapered shape.

また、ドレナージ・チューブlの先端部で、前記加温部
2の両端部の側壁には、中空部lO内と外部との間を連
通ずる複数の流通穴11を開設させている。
Furthermore, at the distal end of the drainage tube 1, a plurality of communication holes 11 are provided in the side walls of both ends of the heating section 2 to communicate between the inside of the hollow section 10 and the outside.

ボ1記加温部2は、ドレナージ・チューブlの先端部近
くに設けられ、胆管癌Kに対して胆管Bの内面側から直
接接触させることによって、癌細胞を局部的に加温して
変性壊死に陥らせるための部分であり、この実施例では
その熱源として電熱ヒータ20か用いられている。
The heating unit 2 is provided near the distal end of the drainage tube l, and is brought into direct contact with the bile duct cancer K from the inner surface of the bile duct B to locally heat the cancer cells and degenerate them. This is a part to cause necrosis, and in this embodiment, an electric heater 20 is used as a heat source.

そして、この電熱ヒータ20は、加温部2のバイブ壁内
部に埋設状態に設けられたコイル状のニクロム線20a
によって構成され、該ニクロム線20aの両端部は、パ
イプ壁内部に沿って埋設された導線21.21を介し°
Cドレナージ・チューブLの基端側から外部に配線され
ている。
The electric heater 20 includes a coiled nichrome wire 20a buried inside the wall of the vibrator of the heating section 2.
Both ends of the nichrome wire 20a are connected through conducting wires 21 and 21 buried along the inside of the pipe wall.
It is wired externally from the proximal end of the C drainage tube L.

尚、この加温部2の長さは胆管癌の長さに応じて任意に
選択使用できるように、加温部2の長さを異にする多種
類のドレナージ・チューブlを形成しておく。
Incidentally, many types of drainage tubes l having different lengths of the heating section 2 are formed so that the length of the heating section 2 can be arbitrarily selected and used depending on the length of the cholangiocarcinoma. .

前記測温体3は、加温部2の温度を直接的に検知するた
めの1段であって、この実施例では熱電対式の測温体3
0か用いられ、その先端測温接点30aか前記加温部2
の中央部になるように該加温部2のパイプ壁内部に埋設
した状IEに設けられている。
The temperature measuring element 3 is a stage for directly detecting the temperature of the heating section 2, and in this embodiment, it is a thermocouple type temperature measuring element 3.
0 is used, and its tip temperature measuring contact 30a or the heating section 2
It is provided in a shape IE buried inside the pipe wall of the heating section 2 so as to be located in the center of the pipe wall.

そして、該熱電対式測温体30の両端部は、パイプ壁内
部に沿って埋設された導線31.31を介してドレナー
ジ・チューブlの基端側から外部に配線されている。
Both ends of the thermocouple temperature sensing element 30 are wired from the proximal end of the drainage tube l to the outside via conductive wires 31 and 31 buried along the inside of the pipe wall.

前記温度調節手段4は、前記測温体3による検知温度に
基づいて加温部2の温度を調節するための1段であって
、この実施例では、第2図のブロック図で示すように、
測温体3からの入力信号aにノ、(づいて検知された温
度信号すを出力する測温回路40と、訣0温回路40か
らの温度信号すに基づいて温度表示をする温度表示部4
1と、i′Ij制御回路へ温度設定値信号C及び設定時
間値信号dを出力する温度・時間設定回路42と、フィ
ードバック信号となる前記温度信号すと温度設定値信号
Cとを比較した上で制御信号eを出力する制御回路43
と、該制御信号eに基づいて電熱ヒータ20のニクロム
線20aに対する出力型ifを増減制御する出力回路4
4と、該出力回路44からの出力電流fの最大値を設足
し、この設定値以上の電流を目動的にカットするための
最大電流−1限回路45と、同じく出力電流fが急激に
上昇したり1&準値を越えた場合、及び温度信号すが設
゛定値を越えた場合に警報信号りを出力する警報値検出
回路46と、出力回路44からの出力回路側の断線状態
を検出して警報信号iを出力する断線検出回路47と、
再警報信号り、iに基づいて音または光による警報を発
する警報表示部48と、各部へ電源を供給する電源回路
49とによって構成されている。
The temperature adjusting means 4 is a stage for adjusting the temperature of the heating section 2 based on the temperature detected by the temperature measuring element 3, and in this embodiment, as shown in the block diagram of FIG. ,
A temperature measuring circuit 40 outputs a detected temperature signal based on the input signal a from the temperature measuring element 3, and a temperature display section displays the temperature based on the temperature signal from the temperature circuit 40. 4
1, the temperature/time setting circuit 42 which outputs the temperature set value signal C and the set time value signal d to the i'Ij control circuit, and the temperature set value signal C which becomes the feedback signal. A control circuit 43 outputting a control signal e at
and an output circuit 4 that increases or decreases the output type if of the electric heater 20 for the nichrome wire 20a based on the control signal e.
4, and a maximum current -1 limit circuit 45 for setting the maximum value of the output current f from the output circuit 44 and intentionally cutting off the current exceeding this set value; An alarm value detection circuit 46 that outputs an alarm signal when the temperature rises or exceeds the 1 & semi-value, or when the temperature signal exceeds the set value, and a disconnection state on the output circuit side from the output circuit 44 is detected. a disconnection detection circuit 47 that outputs an alarm signal i;
It is comprised of an alarm display section 48 that issues an audible or light alarm based on the re-alarm signal i, and a power supply circuit 49 that supplies power to each section.

そして、前記測温体30の導線31.31は測温回路4
0の入力側に接続され、また、ニクロム線20aの導!
ff121.21は出力回路44の出力側に接続されて
いる。
The conducting wires 31 and 31 of the temperature measuring body 30 are connected to the temperature measuring circuit 4.
0 input side, and also the lead of the nichrome wire 20a!
ff121.21 is connected to the output side of the output circuit 44.

次に実施例の作用を胆管癌の治療方法に基づいて説明す
る。
Next, the effects of the examples will be explained based on a method for treating cholangiocarcinoma.

尚、wS3154〜第5図において、Lは肝臓、Dは十
二指腸、Gは胆のう1Mは胃を示す。
In addition, in wS3154 to FIG. 5, L indicates the liver, D indicates the duodenum, G indicates the gallbladder, and 1M indicates the stomach.

(イ)  経皮経肝的胆道ドレナージ工程(第3図及び
第41A) ■1管癌例に対して、まず超音波映像下に経皮経肝的胆
道ドレナージを行なう。
(B) Percutaneous transhepatic biliary drainage process (Figures 3 and 41A) ■ For a case of single-duct cancer, first perform percutaneous transhepatic biliary drainage under ultrasound imaging.

この経皮経肝的胆道ドレナージとは胆肝癌にで閉塞され
て十二指+11D方向へ流れなくなった胆汁が、閉塞部
より肝臓側の血中へ流入することによって生じる黄麻を
、胆管B内まで挿入したドレナージチューブlによって
1体外へ排出させる事により軽減させる、目的で行なわ
れるものである。
This percutaneous transhepatic biliary drainage refers to the bile that is blocked by biliary liver cancer and has stopped flowing in the direction of the 12 fingers + 11D, and the jute produced when the bile flows into the blood on the liver side from the blockage into the bile duct B. This is done for the purpose of alleviating pain by draining it out of the body through an inserted drainage tube.

(0)胆管癌温熱治療工程(第5図) 上述のように、経皮経肝的胆道ドレナージを1週間前後
行なって黄痘を軽減させた後、ドレナージ・チューブl
を更に十二指118D方向へ押し込んで筋部kを貫通さ
せ、加温部2の位置が筋部にと一致するようにする。
(0) Hyperthermia treatment process for cholangiocarcinoma (Figure 5) As mentioned above, after performing percutaneous transhepatic biliary drainage for about a week to alleviate jaundice, the drainage tube
is further pushed in the direction of the twelfth finger 118D to penetrate the muscle part k so that the position of the heating part 2 coincides with the muscle part.

尚、この場合、筋部により1部及び下部の胆管Bを超音
波エコー直視装置やレントゲン直視装置算で十分に造影
して筋部にの長さを測定し、この長さに合った加温部2
を有するドレナージ・チューブlを選定使用する。
In this case, the first part and the lower part of the bile duct B are sufficiently contrasted using an ultrasonic echo direct viewing device or an X-ray direct viewing device, and the length of the muscular portion is measured, and heating is performed according to this length. Part 2
Select and use a drainage tube with a

次に、加温部2の温度か41”C前後に維持されるよう
に温度7A節手段4の温度設定を行ない、また、加温時
間を30分〜1時間程度に設定して筋部にの温熱治療を
行なう。
Next, set the temperature of the temperature 7A node 4 so that the temperature of the heating section 2 is maintained at around 41"C, and set the heating time to about 30 minutes to 1 hour to heat the muscle. Perform heat treatment.

尚、加温部2の設定温度である416C前後は、癌細胞
が変性壊死に陥る温度であり、これに対して正常組繊細
胞の変性壊死に陥る温度はそれより2℃高い43℃前後
であるから、この両者の温度特性の相違を利用して、加
温部2をこの41″C〜43°Cの範囲内になるように
制御させることによって、癌細胞のみを直接的かつ効果
的に温熱治療することかできる。
The set temperature of heating section 2, which is around 416C, is the temperature at which cancer cells undergo degenerative necrosis, whereas the temperature at which normal tissue cells undergo degenerative necrosis is around 43°C, which is 2°C higher. Therefore, by utilizing the difference in temperature characteristics between the two and controlling the heating section 2 to within this range of 41"C to 43C, only cancer cells can be directly and effectively killed. It can be treated with heat.

また1以上のように筋部kft貫通させたドレナージ・
チューブlの加温部2によって隔部にの胆管か閉塞され
た状態となるが、隔部によリーヒ部(肝臓り側)の胆管
B内に溜った胆汁は、流通穴11及び中空部lOを経由
して十二指111D方向(及び体外方向)へ誘導させる
ことかできるので、癌の治療と黄痘の軽減とを同時進行
させることができるのである。
In addition, as in 1 or above, drainage and
The bile duct in the septum becomes obstructed by the heating part 2 of the tube l, but the bile accumulated in the bile duct B in the lehy part (liver side) due to the septum flows through the circulation hole 11 and the hollow part lO. Since it can be guided in the direction of the 12 fingers 111D (and in the direction outside the body) via the tube, cancer treatment and jaundice alleviation can proceed at the same time.

そして、体力が回復して胆管癌の切除手術が可能になる
までの減数期間(約1ケ月)中に、上述のような温熱治
療を週2回程度の頻度で行なうことによって、減員期間
中に癌が増大、移転する可能性を低下させ、若しくは癌
細胞の大部分を壊死に陥らせて縮小させ、よって切除手
術の治療効果を向上させることができるようになる。
Then, during the reduction period (approximately one month) until physical strength has recovered and resection surgery for bile duct cancer is possible, by performing the above-mentioned heat treatment about twice a week, It becomes possible to reduce the possibility of cancer growth and metastasis, or to reduce the size of most cancer cells by causing them to undergo necrosis, thereby improving the therapeutic effect of resection surgery.

更に、切除不能胆管癌に対しても、局所の癌細胞の大部
分を壊死に陥らせることで延命させることができるよう
になる。
Furthermore, the survival of unresectable cholangiocarcinoma can be extended by causing most of the local cancer cells to undergo necrosis.

以上説明してきたように1本実施例の胆管癌治療装置A
にあっては、上述のように構成したことで、以下に述べ
るような効果が得られる。
As explained above, bile duct cancer treatment device A of this embodiment
By configuring as described above, the following effects can be obtained.

■ ドレナージ・チューブlに加温部2を組み込んだも
ので、MUの軽減をはかりながら胆管癌の治療が行なえ
るようになる。
■ A heating section 2 is incorporated into the drainage tube 1, making it possible to treat cholangiocarcinoma while reducing MU.

(リ 切除可能胆管癌に対しては、約1ケ月の減数期間
を利用して治療か出来、この期間の癌進展を防止でき、
さらに、切除時にどうしても残存する可悌性のあるミク
ロレベルの癌細胞に対しても効果がある可11性かある
(Resectable cholangiocarcinoma can be treated using a reduction period of about 1 month, and cancer progression can be prevented during this period.
Furthermore, there is a possibility that it is effective against flexible microscopic cancer cells that inevitably remain after resection.

■ 切除不能胆管癌に対して、現在、抗癌剤、免疫療法
、放射線治療か行なわれているが、直接的な治療法は行
なわれておらず、本装置では局所の癌細胞に対して直接
的な治療が行なえるので、治療効果が極めて高いもので
ある。
■ Currently, anticancer drugs, immunotherapy, and radiation therapy are being used for unresectable cholangiocarcinoma, but no direct treatment is available, and this device does not directly target local cancer cells. Since it can be treated, it has an extremely high therapeutic effect.

に) 手術、抗癌剤、免疫療法剤の投与、放射線治療な
どの現在性なっている治療法と競合するものではなく、
相加、相乗的な治療を行なうことができる。
) It does not compete with current treatments such as surgery, anticancer drugs, immunotherapy drugs, and radiation therapy.
Additive or synergistic treatments can be used.

■ 胆汁内に浮遊する癌細胞に対しても死滅させる効果
がある。
■ It also has the effect of killing cancer cells floating in bile.

■ マイクロ波に比べて、癌の範囲を均等に加温できる
■ Compared to microwaves, it can heat the cancer area evenly.

■ 温度測定をドレナージ・チューブl内の加温部2で
直接的に行なうので安全性が高い。
■ High safety because temperature measurement is performed directly in the heating section 2 inside the drainage tube 1.

(Φ 本、装置は全体を比較的憬価で作ることができ、
マイクロ波を用いた装置とか、体外加温装置に比べ極め
て安価である。
(Φ The entire book and device can be made at a relatively low price,
It is extremely inexpensive compared to devices that use microwaves or external warming devices.

以上、本発明の実施例を図面により詳述してきたが、具
体的な構成はこの実施例に限られるものではなく、本発
明の要旨を逸脱しない範囲における設計変更等があって
も本発明に含まれる。
Although the embodiments of the present invention have been described above in detail with reference to the drawings, the specific configuration is not limited to these embodiments, and the present invention may be modified without departing from the gist of the present invention. included.

例えば、実施例では、加温部の熱源となる電熱ヒータと
してコイル状のニクロム線を用いる場合を例にとったが
、その素材や形状等は任意である。
For example, in the embodiment, a coiled nichrome wire is used as the electric heater serving as the heat source of the heating section, but the material, shape, etc. thereof may be arbitrary.

また、実施例では、測温体として熱電対式のものを用い
た場合を例にとったか、他の公知の測温体であってもよ
い。
Further, in the embodiment, a thermocouple type temperature measuring element is used as an example, but other known temperature measuring elements may be used.

また、実施例では、温度調節手段とし°(、目動J!I
wIが可能な手段を用いた場合を示したか、その具体的
手段には限定されず、また、温度表示に基づいてPa5
eを行なうものであってもよい。
In addition, in the embodiment, the temperature adjustment means is
It is not limited to the specific means, and whether Pa5 is used based on the temperature display.
It may also be one that performs e.

(発明の効果) 以ト説明してきたように本発明の胆管癌治療装置にあっ
ては、ドレナージ・チューブの先端部近くには電熱ヒー
タによる加温部と、該加温部の温度を測定する測温体と
を備え、かつ、ドレナージ・チューブの基端部側には測
温体による検知温度に基づいて加温部の温度a1節が可
能な温度調節手段を備えたことで、隔部に挿通させた加
温部を41 ”C前後に加温させることによって、癌細
胞を変性壊死に陥らせることができ、 また、加温部がドレナージ・チューブに備えられ、かつ
、該ドレナージ・チューブの先端部で少なくとも加温部
よりは基端側の側壁には中空部内と外部との間を挿通ず
る流通穴を備えたことで、肝臓から放出された胆汁をド
レナージ・チューブの連通穴から中空部を経由して十二
指腸側へ誘導することができる。
(Effects of the Invention) As explained above, in the cholangiocarcinoma treatment device of the present invention, there is a heating section using an electric heater near the distal end of the drainage tube, and the temperature of the heating section is measured. In addition, the proximal end of the drainage tube is equipped with a temperature adjustment means that can adjust the temperature of the heating section a1 based on the temperature detected by the temperature sensor. Cancer cells can be caused to undergo degenerative necrosis by heating the inserted heating part to around 41"C. Furthermore, if the heating part is provided in the drainage tube and the drainage tube is At the distal end, at least the side wall on the proximal side of the heating section is equipped with a communication hole that passes between the inside of the hollow part and the outside, so that bile released from the liver can be transferred from the communication hole of the drainage tube to the hollow part. It can be guided to the duodenum side via.

従っ゛C1経皮経叶的1iti道ドレナージを行ないな
がら胆管筋を直接的かつ局部的に加熱治療することがで
きるようになるという効果が得られる。
Therefore, it is possible to directly and locally heat treat the bile duct muscle while performing C1 percutaneous percutaneous drainage.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は本発明実施例の胆管癌治療装δを示す説明図、
第2121ffは温度調節手段の詳細を示すブロック1
56、第3図は経皮経肝的胆道ドレナージ工程を示す説
明図、第4図は同要部拡大図、第5図は胆管筋温熱治療
工程を示す説明図である。 l:ドレナージ・チューブ 2:加温部 3二測温体 4:温度調節手段 lO:中空部 11:流通穴 20:電熱ヒータ K : lip管癌 B : 1ljj管
FIG. 1 is an explanatory diagram showing a cholangiocarcinoma treatment device δ according to an embodiment of the present invention;
No. 2121ff is block 1 showing details of temperature control means
56, FIG. 3 is an explanatory diagram showing the percutaneous transhepatic biliary drainage process, FIG. 4 is an enlarged view of the same essential part, and FIG. 5 is an explanatory diagram showing the bile duct muscle thermal treatment process. 1: Drainage tube 2: Heating part 3 2 Temperature measuring body 4: Temperature adjustment means 1O: Hollow part 11: Distribution hole 20: Electric heater K: Lip tube cancer B: 1ljj tube

Claims (1)

【特許請求の範囲】[Claims] 1)体外から胆管内に至るまでの間に挿入可能なサイズ
と可撓性とを備え、かつ、胆管内に溜った胆汁を体外へ
誘導するための中空部を備えた中空パイプ状のドレナー
ジ・チューブであって、前記ドレナージ・チューブの先
端部近くには電熱ヒータを熱源とする加温部と、該加温
部の温度を測定する測温体とを備え、かつ、ドレナージ
・チューブの基端部側には測温体による検知温度に基づ
いて加温部の温度調節が可能な温度調節手段を備えると
共に、ドレナージ・チューブの先端部で少なくとも加温
部よりは基端側の側壁には中空部内と外部との間を連通
する流通穴を備えたことを特徴とする胆管癌治療装置。
1) A hollow pipe-shaped drainage tube that is large enough and flexible enough to be inserted between the outside of the body and into the bile duct, and that has a hollow part for guiding bile accumulated in the bile duct to the outside of the body. The drainage tube is provided with a heating part using an electric heater as a heat source near the distal end of the drainage tube, and a temperature measuring element for measuring the temperature of the heating part, and a proximal end of the drainage tube. The drainage tube is equipped with a temperature control means that can adjust the temperature of the heating section based on the temperature detected by the thermometer, and a hollow side wall is provided at least on the proximal side of the heating section at the distal end of the drainage tube. A cholangiocarcinoma treatment device characterized by having a communication hole that communicates between the inside and the outside.
JP62134355A 1987-05-28 1987-05-28 Cholangiocarcinoma treatment apparatus Granted JPS63294852A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62134355A JPS63294852A (en) 1987-05-28 1987-05-28 Cholangiocarcinoma treatment apparatus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62134355A JPS63294852A (en) 1987-05-28 1987-05-28 Cholangiocarcinoma treatment apparatus

Publications (2)

Publication Number Publication Date
JPS63294852A true JPS63294852A (en) 1988-12-01
JPH0247219B2 JPH0247219B2 (en) 1990-10-18

Family

ID=15126429

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62134355A Granted JPS63294852A (en) 1987-05-28 1987-05-28 Cholangiocarcinoma treatment apparatus

Country Status (1)

Country Link
JP (1) JPS63294852A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH061423U (en) * 1992-06-12 1994-01-11 丸玉産業有限会社 barricade
JPH061424U (en) * 1992-06-12 1994-01-11 丸玉産業有限会社 barricade
JPH06185023A (en) * 1992-12-15 1994-07-05 Mitsui Constr Co Ltd Barricade fence and fence component
CN106659574B (en) * 2014-04-11 2018-12-25 微仙美国有限公司 Implantation material delivery system

Also Published As

Publication number Publication date
JPH0247219B2 (en) 1990-10-18

Similar Documents

Publication Publication Date Title
CN104254291B (en) The method and apparatus for the tissue rebuild near the tissue or body passageway of body passage
JP7133058B2 (en) Urination catheter and method for accelerated introduction into urinary tract
JP6580034B2 (en) Target nerve fiber regulation
CN105228694B (en) Medical systems and methods for modulating nerves
ES2560180T3 (en) Systems for thermally induced renal neuromodulation
US5220927A (en) Urethral inserted applicator for prostate hyperthermia
EP2731531B1 (en) Renal nerve denervation via the renal pelvis
EP2208506A1 (en) Intraluminar oncothermia catheter
US5599346A (en) RF treatment system
US4920978A (en) Method and apparatus for the endoscopic treatment of deep tumors using RF hyperthermia
US20160193469A1 (en) Neuromodulation system and related methods
US20150032105A1 (en) Transurethral systems and methods for ablation treatment of prostate tissue
JP2016097310A (en) Catheter apparatuses having multi-electrode arrays for renal neuromodulation and associated systems and methods
WO1993008876A1 (en) Urethral inserted applicator for prostate hyperthermia
US10232188B2 (en) Single cable apparatus and method for hyperthermic treatments
CN110062606A (en) Pulmonary vein isolation foley's tube
JP6118435B2 (en) Catheter for monitoring biological environment
JPS63294852A (en) Cholangiocarcinoma treatment apparatus
EP3072468B1 (en) Medical ablation system with reduced stray heating
WO2018039225A1 (en) Catheter system and a system for treating endometriosis
JPH06501410A (en) Electromagnetic capacitive coupling applicator device for prostatic hyperplasia treatment
JP6751842B2 (en) Biological heating equipment
CN109303602A (en) A kind of multi-pole rf heat treatment catheter
CN116867454A (en) Irrigation associated with pulsed electric field ablation
ES2560904T3 (en) Systems for thermally induced renal neuromodulation